Table 2.
The relationship of glycemic control for HbA1c and blood glucose in T2DM subjects
| HbA1c | Glucose | |||
|---|---|---|---|---|
| Median (IQR) | P-value | Median (IQR) | P-value | |
| Hypertension-No | 7.7 (6.7–9.4) | 0.730 | 8.9 (6.6–12.8) | 0.023 |
| Hypertension-Yes | 8.0 (6.7–9.3) | 7.8 (6.1–10.6) | ||
| Dyslipidemia-No | 7.7 (6.6–9.2) | 0.360 | 8.5 (6.3–13.1) | 0.419 |
| Dyslipidemia-Yes | 8.0 (6.8–9.4) | 8.2 (6.2–10.7) | ||
| Retinopathy-No | 7.4 (6.6–9.1) | 0.001 | 8.1 (6.3–10.7) | 0.599 |
| Retinopathy-Yes | 8.6 (7.3–9.8) | 8.6 (6.2–10.9) | ||
| Neuropathy-No | 7.8 (6.7–9.2) | 0.119 | 8.2 (6.2–10.8) | 0.325 |
| Neuropathy-Yes | 8.2 (7.2–9.7) | 8.5 (6.7–11.3) | ||
| PAD-No | 7.9 (6.7–9.3) | 0.970 | 8.3 (6.2–10.8) | 0.757 |
| PAD-Yes | 7.3 (6.7–9.7) | 7.8 (7.2–14.9) | ||
| CAD-No | 7.8 (6.7–9.3) | 0.287 | 8.4 (6.3–10.9) | 0.645 |
| CAD-Yes | 8.1 (6.9–9.9) | 8.1 (6.2–9.5) | ||
| Stroke-No | 7.8 (6.7–9.3) | 0.297 | 8.3 (6.1–10.9) | 0.576 |
| Stroke-Yes | 8.8 (6.9–9.8) | 8.5 (7.1–10.9) | ||
PAD Peripheral artery disease, CAD coronary artery disease